Neumora Therapeutics Inc (NMRA) Stock Price, Quote & News

Company Profile

Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases in the United States. The company develops navacaprant (NMRA-140), a novel once-daily oral kappa opioid receptor antagonist, which is in phase 3 clinical trials for the treatment of major depressive disorder. It also develops NMRA-511 that is in phase 1 clinical trials in patients with agitation associa...

Industry: Biotechnology

Sector: Healthcare

Phone: 857 760 0900

Website: www.neumoratx.com

Address:

490 Arsenal Way, Suite 200, Watertown, United States

Mr_GA Aug. 18 at 8:10 PM

$NMRA Increased my NMRA holdings by 25% today. I actually averaged up, as most of my shares were purchased in the .80 cent range. I am a long term holder, and think good things are down the road for NMRA. I really feel there is the possibility of a big pharma buy-out in late 2026. NMRA has multiple candidates in its pipeline. We may have some new investors here who have not seen this linked article. https://www.investing.com/news/analyst-ratings/hc-wainwright-reiterates-buy-rating-on-neumora-therapeutics-stock-93CH-4129845

1 · Reply

InvestorCG Aug. 18 at 7:52 PM

$NMRA sad volume today.

0 · Reply

StockScanners Aug. 16 at 3:37 AM

$NMRA keep watch if this holds above 1.29

0 · Reply

StocksNCash Aug. 15 at 11:03 PM

$NMRA man, we're over the EMAs but it's an ugly candle. Hoping for some conviction next week

1 · Reply

tazzcrazy Aug. 15 at 5:00 PM

$NMRA Lets rock and roll all next week! 🚀

0 · Reply

InvestorCG Aug. 15 at 4:39 PM

$NMRA Amazing how thin this trades when you don't have a D level financier shorting into the market. Now if only they can get quality IR in there and regain trust of the institutional buyer.

0 · Reply

StocksNCash Aug. 15 at 2:20 AM

$NMRA would really like a close above the 9 and 21 EMAs... Optimistic still

0 · Reply

op211 Aug. 14 at 10:05 PM

$NMRA they have a new office (yay!)

1 · Reply

XQuise Aug. 14 at 10:02 AM

$NMRA

0 · Reply

iQuicky Aug. 13 at 1:16 PM

$NMRA promising

1 · Reply

Neumora Therapeutics, Inc. (NMRA) Q2 2025 Earnings Call Transcript

Aug 6, 2025, 4:05 PM EDT - 12 days ago

Neumora Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update

Jul 23, 2025, 7:00 AM EDT - 26 days ago

Neumora Therapeutics to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025

Jul 9, 2025, 7:00 AM EDT - 5 weeks ago

Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study of M4 Positive Allosteric Modulator NMRA-861

May 12, 2025, 7:18 PM EDT - 3 months ago

Neumora Therapeutics, Inc. (NMRA) Q1 2025 Earnings Call Transcript

May 12, 2025, 4:01 PM EDT - 3 months ago

Neumora Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

Apr 28, 2025, 7:00 AM EDT - 4 months ago

Neumora Therapeutics to Report First Quarter 2025 Financial Results on Monday, May 12, 2025

Apr 4, 2025, 4:05 PM EDT - 4 months ago

NMRA Deadline: NMRA Investors with Losses in Excess of $100K Have Opportunity to Lead Neumora Therapeutics, Inc. Securities Lawsuit First Filed by The Firm

Mar 30, 2025, 4:00 PM EDT - 5 months ago

NMRA Deadline: NMRA Investors Have Opportunity to Lead Neumora Therapeutics, Inc. Securities Lawsuit First Filed by The Firm

Mar 27, 2025, 5:45 AM EDT - 5 months ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 7, 2025 in Neumora Therapeutics, Inc. Lawsuit - NMRA

Mar 26, 2025, 2:19 AM EDT - 5 months ago

NMRA Investors Have Opportunity to Lead Neumora Therapeutics, Inc. Securities Lawsuit First Filed by The Firm

Mar 15, 2025, 9:29 AM EDT - 5 months ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Neumora Therapeutics

Mar 13, 2025, 10:19 AM EDT - 5 months ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Neumora Therapeutics

Mar 6, 2025, 12:17 PM EST - 5 months ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 7, 2025 in Neumora Therapeutics, Inc. Lawsuit – NMRA

Mar 4, 2025, 8:30 AM EST - 5 months ago

Neumora Therapeutics to Present at Leerink Global Healthcare Conference

Mar 3, 2025, 11:37 AM EST - 6 months ago

Neumora Therapeutics, Inc. (NMRA) Q4 2024 Earnings Call Transcript

Mar 3, 2025, 7:00 AM EST - 6 months ago

Neumora Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Feb 27, 2025, 5:45 AM EST - 6 months ago

Investors in Neumora Therapeutics, Inc. Should Contact The Gross Law Firm Before April 7, 2025 to Discuss Your Rights - NMRA

Feb 26, 2025, 8:46 PM EST - 6 months ago

Robbins LLP Reminds Neumora Therapeutics, Inc. (NMRA) Investors With Large Losses to Contact the Firm to Learn How They Can Recover for Their Losses

Feb 26, 2025, 1:32 PM EST - 6 months ago

Investors in Neumora Therapeutics, Inc. Should Contact The Gross Law Firm Before April 7, 2025 to Discuss Your Rights – NMRA

Feb 20, 2025, 5:41 PM EST - 6 months ago

NMRA Investors are Suing Neumora Therapeutics, Inc.; Contact Robbins LLP for More Information

Feb 19, 2025, 10:08 PM EST - 6 months ago

NMRA REMINDER: Kessler Topaz Meltzer & Check, LLP Urges NMRA Investors with Losses to Contact the Firm

Feb 13, 2025, 7:00 AM EST - 6 months ago

Neumora Therapeutics Announces Leadership Transition

Mr_GA Aug. 18 at 8:10 PM

1 · Reply

InvestorCG Aug. 18 at 7:52 PM

$NMRA sad volume today.

0 · Reply

StockScanners Aug. 16 at 3:37 AM

$NMRA keep watch if this holds above 1.29

0 · Reply

StocksNCash Aug. 15 at 11:03 PM

$NMRA man, we're over the EMAs but it's an ugly candle. Hoping for some conviction next week

1 · Reply

tazzcrazy Aug. 15 at 5:00 PM

$NMRA Lets rock and roll all next week! 🚀

0 · Reply

InvestorCG Aug. 15 at 4:39 PM

$NMRA Amazing how thin this trades when you don't have a D level financier shorting into the market. Now if only they can get quality IR in there and regain trust of the institutional buyer.

0 · Reply

StocksNCash Aug. 15 at 2:20 AM

$NMRA would really like a close above the 9 and 21 EMAs... Optimistic still

0 · Reply

op211 Aug. 14 at 10:05 PM

$NMRA they have a new office (yay!)

1 · Reply

XQuise Aug. 14 at 10:02 AM

$NMRA

0 · Reply

iQuicky Aug. 13 at 1:16 PM

$NMRA promising

1 · Reply

op211 Aug. 13 at 12:23 PM

$NMRA earnings ...

0 · Reply

XQuise Aug. 13 at 11:50 AM

$NMRA 🤞🏻

0 · Reply

StocksNCash Aug. 13 at 3:21 AM

$NMRA as they say, green is green. But need to show some strength by closing (and staying) above the 9 and 21 EMAs

0 · Reply

InvestorCG Aug. 12 at 1:40 PM

$NMRA Usually when a 13g has been filed, the shares have already been shorted against the dilution and closed. Let's hope that is the last crappy funding deal this company gets.

0 · Reply

cloudforever Aug. 11 at 3:37 PM

$NMRA 😕 😞...

0 · Reply

Mr_GA Aug. 11 at 2:15 PM

$NMRA Good article regarding NMRA's future prospects. My apologies to the original poster of this link, as I do not remember who you were to give credit to you. Anyway, good read fellow investors. http://beyondspx.com/article/neumora-therapeutics-catalysts-ahead-despite-setback-fueling-a-novel-neuroscience-narrative-nmra

0 · Reply

Mr_GA Aug. 11 at 2:04 PM

$NMRA Do some research into NMRA and you will find they previously (and may still have) affiliations with big pharma companys Amgen and Biogen. NMRA has several candidates in their pipeline. IMO, the present time may be a good entry point, price could possibly drop a little from here though. Personally, I feel NMRA will be a big pharma buy-out candidate in late 2026 if they have positive results from some of their candidates. I bought a lot of my shares in the .79-.80 cent range, so not worried about small price drops, as this is a long term hold for me. I will just keep it parked, and see what happens in 2026. Good luck fellow investors. https://www.investing.com/news/analyst-ratings/hc-wainwright-reiterates-buy-rating-on-neumora-therapeutics-stock-93CH-4129845

0 · Reply

Mr_GA Aug. 11 at 1:49 PM

$NMRA Bad link first time. https://www.investing.com/news/analyst-ratings/hc-wainwright-reiterates-buy-rating-on-neumora-therapeutics-stock-93CH-4129845

0 · Reply

Mr_GA Aug. 11 at 1:48 PM

$NMRA https://www.google.com/amp/s/m.investing.com/news/analyst-ratings/hc-wainwright-reiterates-buy-rating-on-neumora-therapeutics-stock-93CH-4129845%3fampMode=1

0 · Reply

XQuise Aug. 8 at 6:41 PM

$NMRA added more here.. waiting for next week 🙂‍↕️🫦

1 · Reply

InvestorCG Aug. 8 at 4:21 PM

$NMRA very low volume selloff here. Shows ZERO institutional support on the stock right now. IR is invisible.

0 · Reply

InvestorCG Aug. 8 at 2:37 PM

$NMRA Company should have made separated PR's...the obesity drug got buried into the quarterly financials. These guys need to do a much better job with IR obviously.

1 · Reply

Market Cap	263.97M
Revenue (ttm)	0.00
Net Income (ttm)	-243.79M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.11

Volume	359,980
Avg Vol	1,654,092
Day's Range	N/A - N/A
Shares Out	161.95M
Stochastic %K	62%
Beta	2.91
Analysts	Sell
Price Target	$7.00